Condition
Immunocompromised Host clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Immunocompromised Host clinical trials that are recruiting, at sites in 2 countries (most in Argentina (1), Canada (1)). 1 was first registered in the last 30 days. By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1New in 30 days
- 2Countries
All recruiting trials (2)
-
Aztreonam-Avibactam in Immunocompromised Patients with Multidrug-Resistant Infections
This study tests how well and how safely aztreonam-avibactam works in adults with weakened immune systems who have highly resistant Enterobacterales infections.
-
Evaluating COVID-19 and influenza vaccine schedules for immunocompromised individuals
This study is testing different ways to give COVID-19 and flu vaccines to people with weakened immune systems to see which method works best for their protection.
Related topics
Quick answers
How many Immunocompromised Host clinical trials are recruiting right now?
2, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Argentina (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.